Garrett Wollman on Nostr: npub1vu7uz…gnmuv npub1psdfx…99sr7 80% of promising, well-founded, evidence-based ...

npub1vu7uztz0rtxpejd095nl7k78kangchcu58s7cpnt05un5l2n9rsshgnmuv (npub1vu7…nmuv) npub1psdfxfpxz2cwmmnsk60y3nqpn2tqh9n24h4hstvfkwvr6eaek9js499sr7 (npub1psd…9sr7) 80% of promising, well-founded, evidence-based drug candidates fail after they get to the clinic, often after setting a billion &currency_unit()s on fire. The windfall from 2/10 successful drugs cross-subsidizes the 8/10 failures. Find a way to fix that and you're well on your way to lower prices and lower profits. That probably involves the public assuming more of the risk of drug development.